filmarray
respiratori
viru
panel
detect
viral
agent
respiratori
specimen
use
polymeras
chain
reaction
perform
filmarray
respiratori
viral
test
core
laboratori
region
children
hospit
provid
servic
hour
day
day
week
averag
median
turnaround
time
hour
respect
contrast
hour
document
year
previous
onsit
refer
laboratori
use
direct
fluoresc
assay
dfa
detect
viral
agent
studi
period
rhinoviru
detect
coronaviru
sampl
use
filmarray
virus
would
detect
dfa
follow
patient
influenza
influenza
b
receiv
care
emerg
depart
ed
overal
patient
given
oseltamivir
time
manner
defin
receiv
drug
ed
prescript
ed
prescript
within
hour
ed
discharg
result
demonstr
molecular
technolog
success
deploy
nonspecialti
highvolum
multidisciplinari
core
laboratori
acut
respiratori
infect
lead
caus
outpati
visit
hospit
young
children
especi
winter
spring
acut
respiratori
infect
caus
viral
agent
primari
secondari
bacteri
infect
occur
less
frequent
without
definit
diagnosi
patient
viral
infect
like
receiv
unnecessari
antibacteri
agent
therefor
laboratori
test
provid
accur
time
determin
infecti
agent
associ
viral
respiratori
diseas
import
broad
array
test
avail
detect
viral
respiratori
agent
rapid
antigen
test
avail
individu
respiratori
virus
influenza
influenza
b
respiratori
syncyti
viru
rsv
howev
test
low
sensit
specif
sever
molecular
test
develop
detect
viral
rna
dna
use
polymeras
chain
reaction
pcr
method
test
show
high
sensit
specif
molecular
test
technic
challeng
time
consum
requir
experienc
special
medic
technologist
usual
perform
larg
medic
center
highli
special
molecular
virolog
laboratori
limit
hour
oper
filmarray
idaho
technolog
salt
lake
citi
ut
small
desktop
close
singlepiec
flow
realtim
pcr
system
endtoend
molecular
system
includ
autom
nucleic
acid
extract
initi
revers
transcript
multiplex
pcr
follow
singleplex
secondstag
pcr
reaction
detect
specif
viral
agent
singleus
cartridg
respiratori
viru
panel
perform
filmarray
abl
detect
viral
agent
respiratori
specimen
test
requir
minut
handson
time
minut
instrument
time
comparison
filmarray
respiratori
viru
panel
detect
viral
agent
respiratori
specimen
use
polymeras
chain
reaction
perform
filmarray
respiratori
viral
test
core
laboratori
region
children
hospit
provid
servic
hour
day
day
week
averag
median
turnaround
time
hour
respect
contrast
hour
document
year
previous
onsit
refer
laboratori
use
direct
fluoresc
assay
dfa
detect
viral
agent
studi
period
rhinoviru
detect
coronaviru
sampl
use
filmarray
virus
would
detect
dfa
follow
patient
influenza
influenza
b
receiv
care
emerg
depart
ed
overal
patient
given
oseltamivir
time
manner
defin
receiv
drug
ed
prescript
ed
prescript
within
hour
ed
discharg
result
demonstr
molecular
technolog
success
deploy
nonspecialti
highvolum
multidisciplinari
core
laboratori
acut
respiratori
infect
lead
caus
outpati
visit
hospit
young
children
especi
winter
spring
acut
respiratori
infect
caus
viral
agent
primari
secondari
bacteri
infect
occur
less
frequent
without
definit
diagnosi
patient
viral
infect
like
receiv
unnecessari
antibacteri
agent
therefor
laboratori
test
provid
accur
time
determin
infecti
agent
associ
viral
respiratori
diseas
import
broad
array
test
avail
detect
viral
respiratori
agent
rapid
antigen
test
avail
individu
respiratori
virus
influenza
influenza
b
respiratori
syncyti
viru
rsv
howev
test
low
sensit
specif
sever
molecular
test
develop
detect
viral
rna
dna
use
polymeras
chain
reaction
pcr
method
test
show
high
sensit
specif
molecular
test
technic
challeng
time
consum
requir
experienc
special
medic
technologist
usual
perform
larg
medic
center
highli
special
molecular
virolog
laboratori
limit
hour
oper
filmarray
idaho
technolog
salt
lake
citi
ut
small
desktop
close
singlepiec
flow
realtim
pcr
system
endtoend
molecular
system
includ
autom
nucleic
acid
extract
initi
revers
transcript
multiplex
pcr
follow
singleplex
secondstag
pcr
reaction
detect
specif
viral
agent
singleus
cartridg
respiratori
viru
panel
perform
filmarray
abl
detect
viral
agent
respiratori
specimen
test
requir
minut
handson
time
minut
instrument
time
comparison
studi
filmarray
molecular
test
respiratori
viral
agent
show
compar
result
part
preimplement
plan
survey
clinic
laboratori
unit
state
laboratori
perform
test
gener
laboratori
rest
perform
test
microbiolog
virolog
molecular
laboratori
reason
gener
medic
technologist
proper
train
would
abl
perform
test
provid
hour
per
day
day
per
week
servic
emerg
depart
ed
urgent
care
center
decid
perform
test
core
laboratori
core
laboratori
rapid
respons
facil
staf
approxim
fulltim
equival
fte
employe
provid
analysi
encompass
autom
chemistri
hematolog
coagul
urinalysi
blood
ga
analysi
select
therapeut
drug
monitor
addit
individu
manual
test
pregnanc
test
cardiac
marker
drug
abus
screen
sickl
cell
screen
occult
blood
heterophil
antibodi
also
perform
core
laboratori
current
microbiolog
laboratori
night
shift
core
technologist
perform
cultur
setup
gram
stain
core
specimen
process
test
design
base
lean
singlepiec
flow
principl
without
batch
core
laboratori
alreadi
involv
work
flow
institut
filmarray
rel
simpl
studi
describ
implement
filmarray
core
laboratori
provid
rapid
servic
respiratori
viru
diagnosi
pediatr
patient
year
age
care
hospit
urgent
care
clinic
underw
respiratori
viral
pcr
test
decemb
april
includ
studi
filmarray
assay
midturbin
nasal
swab
collect
use
nylon
flock
swab
copan
diagnost
murrieta
ca
immedi
place
univers
transport
media
utm
copan
diagnost
nurs
staff
collect
sampl
train
techniqu
decemb
initi
filmarray
assay
specimen
utm
test
soon
receiv
laboratori
institut
filmarray
panel
direct
fluoresc
assay
dfa
test
use
respiratori
specimen
nasal
wash
prefer
specimen
type
specimen
submit
dfa
ed
previou
year
nasal
wash
virus
present
respiratori
sampl
test
use
filmarray
respiratori
panel
detect
viral
agent
includ
adenoviru
coronaviru
coronaviru
human
metapneumoviru
rhinovirusenteroviru
influenza
influenza
influenza
influenza
influenza
b
parainfluenza
rsv
sampl
load
test
cartridg
ventil
hood
hydrat
pouch
ml
hydrat
solut
ml
respiratori
sampl
dilut
ml
sampl
buffer
ml
inject
sampl
pouch
load
onto
instrument
enter
sampl
identif
instrument
start
result
avail
approxim
hour
test
pouch
contain
reagent
nucleic
acid
extract
revers
transcript
firststep
multiplex
pcr
amplif
secondstep
realtim
pcr
amplif
singl
specif
primer
pair
viral
agent
secondstep
pcr
perform
triplic
softwar
automat
analyz
melt
curv
secondstep
pcr
report
result
posit
neg
first
molecular
test
implement
core
laboratori
microbiolog
staff
assist
initi
test
valid
personnel
train
multipl
continu
educ
session
given
core
laboratori
staff
shift
regard
technic
procedur
well
principl
underli
technolog
core
staff
compet
evalu
fulli
complet
test
made
avail
clinic
dfa
perform
nasal
wash
sampl
describ
procedur
detect
viral
agent
includ
adenoviru
rsv
human
metapneumoviru
influenza
influenza
b
parainfluenza
howev
could
differenti
among
parainfluenza
turnaround
time
tat
data
filmarray
dfa
collect
use
pathnet
laboratori
clinic
inform
system
cerner
kansa
citi
ks
tat
interv
sampl
log
laboratori
inform
system
insid
laboratori
result
verifi
inform
administr
antivir
therapi
obtain
chart
review
clinic
inform
system
posit
result
viral
agent
tabul
daili
studi
approv
institut
review
board
seattl
children
hospit
seattl
wa
respiratori
viru
test
filmarray
initi
decemb
period
end
april
total
specimen
test
seventyon
percent
sampl
ed
urgent
care
daili
test
volum
vari
averag
daili
volum
first
month
second
month
respect
filmarray
instrument
design
singlespecimen
throughput
requir
minut
instrument
time
purchas
instrument
could
run
simultan
hour
day
averag
median
tat
hour
respect
complet
less
hour
less
hour
molecular
test
avail
sent
respiratori
viral
test
onsit
refer
laboratori
dfa
dfa
test
involv
multipl
handoff
step
laboratori
specimen
transport
refer
laboratori
dfa
specimen
run
batch
time
per
day
depend
volum
respiratori
viru
season
test
time
approxim
hour
period
year
previous
dfa
respiratori
virus
perform
averag
median
tat
dfa
hour
respect
complet
less
hour
tabl
test
volum
respiratori
viru
studi
period
almost
doubl
compar
period
last
year
studi
period
instrument
fail
time
rate
fail
test
includ
qualiti
control
failur
insuffici
vacuum
pouch
pouch
leak
tat
significantli
longer
instrument
reagent
pouch
fail
studi
period
sampl
test
posit
viral
agent
rhinovirusenteroviru
rsv
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
j
n
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
f
e
b
r
u
r
current
guidelin
treat
patient
influenza
b
infect
oseltamivir
indic
medic
given
within
hour
symptom
onset
effect
gener
children
respiratori
symptom
may
seek
brought
medic
attent
immedi
delay
laboratori
test
may
prolong
interv
symptom
onset
administr
medic
treatment
benefit
specif
follow
patient
n
test
posit
influenza
influenza
b
admit
ed
march
mean
median
length
stay
ed
studi
period
hour
respect
patient
respiratori
viral
result
provid
filmarray
avail
patient
discharg
ed
patient
posit
result
call
within
hour
discharg
remain
patient
notifi
result
hour
patient
patient
treat
oseltamivir
ed
patient
given
prescript
ed
prescript
call
anoth
patient
within
hour
discharg
ed
remain
patient
receiv
prescript
oseltamivir
overal
patient
influenza
viru
given
oseltamivir
time
mannerdefin
receiv
drug
ed
prescript
ed
prescript
within
hour
ed
discharg
among
patient
receiv
prescript
report
symptom
hour
ed
visit
patient
show
improv
symptom
accord
parent
followup
appoint
receiv
physician
decis
treat
inform
avail
patient
daili
talli
posit
result
respiratori
viru
season
clearli
demonstr
epidemiolog
multipl
respiratori
viral
agent
present
symptomat
children
receiv
care
institut
contribut
hospitalwid
well
communitywid
public
health
inform
unusu
influenza
b
emerg
later
season
end
februari
peak
april
emerg
influenza
virus
rsv
major
infecti
agent
peak
note
midfebruari
also
found
patient
receiv
live
attenu
influenza
vaccin
less
day
test
posit
influenza
b
retrospect
would
recommend
viral
test
patient
recent
immun
live
vaccin
molecular
test
respiratori
virus
becom
wide
avail
rapidli
deploy
diagnost
laboratori
past
year
therefor
critic
oper
decis
involv
system
choos
meet
patient
care
need
integr
smoothli
laboratori
infrastructur
gener
molecular
test
respiratori
virus
conduct
batch
special
molecular
microbiolog
virolog
laboratori
rare
offer
test
even
night
shift
tat
molecular
test
also
rel
long
rang
hour
filmarray
recent
us
food
drug
administr
fda
approv
pcr
method
detect
respiratori
viral
agent
recent
idaho
technolog
receiv
fda
approv
addit
respiratori
viral
bacteri
agent
includ
coronaviru
coronaviru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
simpl
fulli
autom
sampl
result
tat
singlepiec
throughput
platform
implement
filmarray
core
laboratori
ran
test
respiratori
viral
season
start
filmarray
instrument
volum
test
increas
third
instrument
ad
fourth
one
made
avail
us
backup
redund
instrument
allow
laboratori
continu
perform
test
instrument
oper
implement
filmarray
core
laboratori
significantli
reduc
tat
respiratori
viru
test
report
addit
filmarray
respiratori
viral
panel
includ
viral
agent
includ
previou
test
use
dfa
although
current
treatment
respiratori
viral
infect
limit
influenza
b
detect
viral
agent
valuabl
clinic
suspicion
viral
respiratori
tract
infect
confirm
addit
workup
therapi
avoid
clinician
parent
reassur
addit
earli
treatment
patient
influenza
viru
earli
detect
infecti
agent
import
place
patient
appropri
isol
cohort
rapid
tat
filmarray
test
respiratori
virus
also
use
place
patient
cohort
effect
fact
respiratori
viral
test
perform
primarili
purpos
patient
isol
form
cohort
case
patient
admit
urgent
surgeri
rapid
respiratori
viral
test
quickli
rule
influenza
infect
surgeri
perform
strict
isol
procedur
use
mask
neg
pressur
oper
room
purchas
price
filmarray
respiratori
viral
pcr
panel
per
reagent
pouch
discount
list
price
ad
pouch
failur
rate
addit
qualiti
control
test
cost
approxim
per
test
test
took
approxim
minut
perform
amount
time
requir
packag
sampl
sent
refer
laboratori
add
fte
core
laboratori
addit
test
cost
send
sampl
refer
laboratori
respiratori
viral
test
dfa
actual
price
filmarray
slightli
higher
previou
spent
respiratori
viral
test
dfa
test
perform
previou
year
nasal
wash
prefer
specimen
type
collect
nasal
wash
sampl
result
gener
aerosol
therefor
procedur
room
close
minut
room
could
use
replac
nasal
wash
midturbin
swab
increas
effici
elimin
room
closur
respiratori
viral
test
sampl
collect
ed
potenti
save
hour
ed
room
respiratori
viral
test
perform
cost
save
could
accur
calcul
howev
report
found
reduct
ed
board
time
would
result
addit
daili
revenu
report
calcul
includ
patient
left
without
seen
repres
ed
visit
rate
patient
left
without
seen
institut
opportun
cost
save
institut
probabl
lower
major
drawback
filmarray
singlesampl
throughput
rel
low
sensit
detect
adenoviru
inabl
separ
rhinoviru
enteroviru
furthermor
unabl
quantifi
viral
load
may
also
import
patient
addit
high
detect
rate
rhinoviru
necessarili
interpret
high
rate
acut
rhinoviru
infect
prolong
rate
rhinoviru
shed
report
final
interfac
computer
data
entri
system
current
requir
technologist
verifi
report
result
cleric
error
reduct
peer
review
verif
report
process
data
entri
error
correct
without
affect
patient
care
error
rate
relat
data
entri
less
summari
implement
filmarray
respiratori
panel
core
laboratori
significantli
decreas
time
requir
detect
report
respiratori
virus
patient
influenza
b
treat
rapidli
appropri
possibl
use
dfa
detect
viral
agent
assist
physician
differenti
diagnosi
respiratori
syndrom
isol
patient
admit
hospit
overal
implement
molecularbas
effici
diagnost
test
core
laboratori
first
time
mark
new
era
pediatr
clinic
laboratori
medicin
